Telix Pharmaceuticals Limited (TLX)
Nasdaq: TLX · Pharmaceutical Preparations · North Melbourne, AU · filing with the SEC since 2024
The company now
Telix Pharmaceuticals Limited is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in North Melbourne, AU. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $804 million and a loss of $7.1 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.